Skip to content
Preprint · CC-BY via OpenAlex

Non‐hematopoietic human bone marrow contains long‐lasting, pluripotential mesenchymal stem cells

Domizio Suvà, Guido Garavaglia, Jacques Ménétrey, B Chapuis, Pierre J Hoffmeyer, Laurent Bernheim, Vincent Kindler

Journal of Cellular Physiology · 2003 · ▲ 119 citations

Abstract

Mesenchymal stem cells (MSC) are considered as potential agents for reconstructive and gene-targeting therapies since they differentiate into various cell-lineages, exhibit an extended survival once injected into a host, and can easily be transfected with engineered DNA. MSC are essentially isolated from hematopoietic bone marrow (BM), a process that is rather invasive and may raise ethical concerns. In an attempt to find an alternative source, we evaluated whether non-hematopoietic (nh)BM recovered from femoral heads of patients undergoing hip arthroplasty contained MSC. Ex vivo, 99% of nhBM cells were CD45(+) leukocytes. After culture, leukocytes were replaced by a homogeneous layer of adherent CD45(-) CD14(-) CD34(-) CD11b(-) CD90(+) HLA-ABC(+) cells. Culture doubling time (mean = 4 days, range 1.6-6.7 days) was not correlated with patient age (27-81 years, n = 16). Amplified cultures supported long-term hematopoiesis, and could be differentiated in vitro into adipocytes and chondrocytes. Moreover, a small fraction of nhBM cells spontaneously expressed MyoD1 and formed myotubes, suggesting that myogenic differentiation also occurred. nhBM contained clonogenic cells whose frequency (1/13,000), doubling time (2.1 days), and maximal amplification (up to 10(6)-fold) were not age-related. All 14 clones analyzed (from five patients, ages 27-78 years) differentiated into at least one mesenchymal lineage, and 66% were bipotential (n = 8/12), or tripotential (n = 2/3). In conclusion, nhBM contains pluripotential mesenchymal progenitors which are similar to hematopoietic BM-derived MSC, and whose biological functions are not altered by aging. Furthermore, if MSC-based therapies hold their promises, nhBM may become the source of choice for responding to the increasing demand for MSC.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1002/jcp.10396
Canonical
link ↗
Fetched
2026-10-10 MST

Cite this

APA
Suvà, D., Garavaglia, G., Ménétrey, J., Chapuis, B., Hoffmeyer, P.J., Bernheim, L., &amp; Kindler, V. (2003). Non‐hematopoietic human bone marrow contains long‐lasting, pluripotential mesenchymal stem cells. <em>Journal of Cellular Physiology</em>. https://doi.org/10.1002/jcp.10396
Vancouver
Suvà D, Garavaglia G, Ménétrey J, Chapuis B, Hoffmeyer PJ, Bernheim L, et al. Non‐hematopoietic human bone marrow contains long‐lasting, pluripotential mesenchymal stem cells. Journal of Cellular Physiology. 2003. doi:10.1002/jcp.10396.
BibTeX
@unpublished{domizio2003Nonhem, title = {Non‐hematopoietic human bone marrow contains long‐lasting, pluripotential mesenchymal stem cells}, author = {Domizio Suvà and Guido Garavaglia and Jacques Ménétrey and B Chapuis and Pierre J Hoffmeyer and Laurent Bernheim and Vincent Kindler}, journal = {Journal of Cellular Physiology}, year = {2003}, doi = {10.1002/jcp.10396}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings